Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutationsMeiying Shen, Aishun Jin, Kang Li et al.|Cancer Immunology Immunotherapy|2024Cited by 10
Identification of novel KRASG12D neoantigen specific TCRs and a strategy to eliminate off-target recognitionXiaojian Han, Meiying Shen, Xiaxia Han et al.|Journal of Translational Medicine|2025Cited by 4
Therapeutic potential of T-cell receptor targeting the HLA-A*11:01-restricted KRAS<sup>G12V</sup> neoantigen without cross-recognition of the self-antigen RAB7B in solid tumorsMeiying Shen, Aishun Jin, Yanan Hao et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 3
Therapeutic potential of T cell receptor targeting the HLA-A*11:01-restricted KRASG12V neoantigen without cross-recognition of the self-antigen RAB7B in solid tumorsMeiying Shen, Aishun Jin, Yanan Hao et al.|Research Square|2025Cited by 0
Identification of novel KRASG12D neoantigen specific TCRs and a strategy to eliminate off-target recognitionXiaojian Han, Aishun Jin, Yanan Hao et al.|Research Square|2024Cited by 0